Filtered By:
Source: Thrombosis and Haemostasis
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 528 results found since Jan 2013.
Oral anticoagulant use in patients with morbid obesity: A systematic review and meta-analysis
CONCLUSIONS: Patients with morbid obesity on DOACs had similar risks of stroke/systemic embolism, lower rates of recurrent VTE and major bleeding events compared to those on VKAs. However, the certainty of evidence was low given that studies were mostly observational with high risk of confounding.PMID:34399433 | DOI:10.1055/a-1588-9155
Source: Thrombosis and Haemostasis - August 16, 2021 Category: Hematology Authors: Tzu-Fei Wang Marc Carrier Karine Fournier Deborah M Siegal Gr égoire Le Gal Aur élien Delluc Source Type: research
Atrial Fibrillation Detected by Single Timepoint Handheld ECG Screening and the Risk of Ischemic Stroke
CONCLUSION: The prognosis of single timepoint ECG screen-detected AF is not benign. The risk of stroke is high enough to warrant OAC use, and reduced by OAC.PMID:34399432 | DOI:10.1055/a-1588-8867
Source: Thrombosis and Haemostasis - August 16, 2021 Category: Hematology Authors: Wen Sun Ben Freedman Carlos Martinez Christopher Wallenhorst Bryan Yan Source Type: research
Associations of Coagulation Factor X and XI with Incident Acute Coronary Syndrome and Stroke: A Nested Case-Control Study
CONCLUSION: FXI levels were associated with a greater risk of incident ischemic stroke but not hemorrhagic stroke or ACS. FX levels were not associated with incident ACS or stroke.PMID:34351069 | DOI:10.1111/jth.15486
Source: Thrombosis and Haemostasis - August 5, 2021 Category: Hematology Authors: Huiting Chen Miaoyan Shen Rundong Niu Xuanwen Mu Qin Jiang Rong Peng Yu Yuan Hao Wang Qiuhong Wang Handong Yang Huan Guo Meian He Xiaomin Zhang Tangchun Wu Source Type: research
Impact and Significance of Screening for Atrial Fibrillation in Relation to Stroke and Mortality Risk
Thromb Haemost. 2021 Jul 29. doi: 10.1055/a-1562-0747. Online ahead of print.ABSTRACTNot requested.PMID:34327699 | DOI:10.1055/a-1562-0747
Source: Thrombosis and Haemostasis - July 30, 2021 Category: Hematology Authors: Marco Proietti Giuseppe Boriani Source Type: research
Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control
CONCLUSIONS: Intensive glucose control induced greater alterations in coagulation biomarkers than standard treatment, and these were associated with a favorable functional outcome at 3 months after AIS.PMID:34278192 | PMC:PMC8279129 | DOI:10.1002/rth2.12563
Source: Thrombosis and Haemostasis - July 19, 2021 Category: Hematology Authors: Nina T Gentile A Koneti Rao Hannah Reimer Fabiola Del Carpio-Cano Viswanathan Ramakrishnan Qi Pauls William G Barsan Askiel Bruno iSPOT, Neurological Emergencies Treatment Trials Network (NETT) Investigators Source Type: research
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT: COMMENT from Gruel et al.: RESPONSE from Kahn et al
J Thromb Haemost. 2021 Jul 17. doi: 10.1111/jth.15467. Online ahead of print.ABSTRACTWe acknowledge the commentary of Gruel et al. on our recent letter [1] and are pleased that the authors agree that IdeS may be a potential treatment option for the rare but potentially severe IgG-mediated platelet activation observed in complications to vaccination with ChAdOx1 nCoV-19. It is apparent that our respective but distinct expertise with regard to IdeS has led us to develop this hypothesis in parallel. As we clearly cited in our original letter these authors have previously contributed important evidence that IdeS may be benefic...
Source: Thrombosis and Haemostasis - July 17, 2021 Category: Hematology Authors: Fredrik Kahn Oongh Shannon Lars Bj örck Source Type: research
Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel
CONCLUSION: Patients with aPC undergoing palliative 1st-line chemotherapy with FOLFIRINOX or GN face a high risk for VTE/ATE and its diagnosis is linked to worse clinical outcomes. VTE-risk prediction models have limited ability to sub-stratify thrombotic events in this high-risk scenario.PMID:34255340 | DOI:10.1055/a-1548-4847
Source: Thrombosis and Haemostasis - July 13, 2021 Category: Hematology Authors: Jakob M Riedl Esther Schwarzenbacher Florian Moik Lena Horvath Antonia Gantschnigg Felix Renneberg Florian Posch Dominik A Barth Michael Stotz Martin Pichler Stefan Hatzl Simon Fandler-H öfler Paul Gressenberger Thomas Gary Philipp Jost Richard Greil Cih Source Type: research
